Play the ball - somethings can legitimately be laid at management's feet 100% - I think we left the shrine environment way back didn't we? having said that simply going off with a shotgun hoping at least one pallet will hit is also not worth the response and does nothing to lift the quality of discourse here.
External factors are hitting everyone who are not producing cash which means Kazia management are going to need to be that much more strategic in their thinking going forward. The days of easy money are over - that being said I never wanted to park cash in a hot air machine either playing the pump and dumps so the situation as always returns to the drugs - they work (in humans) or they don't. - paxalisib is attracting attention in a poorly endowed area of oncology in regard available treatments and yesterdays announcement was positive IMHO in regard the ongoing development of paxalisib.
- Forums
- ASX - By Stock
- KZA
- Ann: Kazia paxalisib preclinical DIPG data released at IPSNO
Ann: Kazia paxalisib preclinical DIPG data released at IPSNO, page-13
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online